Last10K.com

Balance Labs, Inc. (BLNC) SEC Filing 10-Q Quarterly Report for the period ending Thursday, March 31, 2022

Balance Labs, Inc.

CIK: 1632121 Ticker: BLNC
Cover - shares
3 Months Ended
Mar. 31, 2022
May 16, 2022
Cover [Abstract]  
Document Type10-Q 
Amendment Flagfalse 
Document Quarterly Reporttrue 
Document Transition Reportfalse 
Document Period End DateMar. 31, 2022 
Document Fiscal Period FocusQ1 
Document Fiscal Year Focus2022 
Current Fiscal Year End Date--12-31 
Entity File Number333-202959 
Entity Registrant NameBALANCELABS, INC. 
Entity Central Index Key0001632121 
Entity Tax Identification Number47-1146785 
Entity Incorporation, State or Country CodeDE 
Entity Address, Address Line One407Lincoln Road 
Entity Address, Address Line TwoSuite 701 
Entity Address, City or TownMiamiBeach 
Entity Address, State or ProvinceFL 
Entity Address, Postal Zip Code33139 
City Area Code(305) 
Local Phone Number907-7600 
Entity Current Reporting StatusNo 
Entity Interactive Data CurrentYes 
Entity Filer CategoryNon-accelerated Filer 
Entity Small Businesstrue 
Entity Emerging Growth Companyfalse 
Entity Shell Companyfalse 
Entity Common Stock, Shares Outstanding 21,674,000

View differences made from one quarter to another to evaluate Balance Labs, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Balance Labs, Inc..

Continue

Assess how Balance Labs, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Balance Labs, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Cover
Condensed Consolidated Statement Of Changes In Stockholders' Deficit (Unaudited)
Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (Parenthetical)
Condensed Consolidated Statement Of Cash Flows (Unaudited)
Condensed Consolidated Statement Of Operations (Unaudited)
Business Organization And Nature Of Operations
Commitments And Contingencies
Commitments And Contingencies (Details Narrative)
Convertible Notes And Notes Payable
Convertible Notes And Notes Payable (Details Narrative)
Going Concern
Going Concern (Details Narrative)
Note Receivable
Note Receivable (Details Narrative)
Related Party Transactions
Related Party Transactions (Details Narrative)
Revision Of Prior Year Immaterial Misstatement
Revision Of Prior Year Immaterial Misstatement (Details Narrative)
Revision Of Prior Year Immaterial Misstatement (Tables)
Schedule Of Equity Method Investments (Details)
Schedule Of Fair Value Of Assets On Recurring Basis (Details)
Schedule Of Joint Venture Of Financial Information (Details)
Schedule Of Property And Equipment (Details)
Schedule Of Revision In Financial Statements (Details)
Stockholders??? Equity
Stockholders??? Equity (Details Narrative)
Stockholders??? Equity (Tables)
Subsequent Events
Subsequent Events (Details Narrative)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Details Narrative)
Summary Of Significant Accounting Policies (Policies)
Summary Of Significant Accounting Policies (Tables)
Summary Of Warrants Outstanding (Details)

Material Contracts, Statements, Certifications & more

Balance Labs, Inc. provided additional information to their SEC Filing as exhibits

Ticker: BLNC
CIK: 1632121
Form Type: 10-Q Quarterly Report
Accession Number: 0001493152-22-013738
Submitted to the SEC: Mon May 16 2022 4:02:02 PM EST
Accepted by the SEC: Mon May 16 2022
Period: Thursday, March 31, 2022
Industry: Management Consulting Services

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/blnc/0001493152-22-013738.htm